Moreover, the molecular mechanism by which the antiaging hormone Klotho regulates TRPV5 activity may prove to be generally applicable in Klotho-mediated prevention of aging.
Introduction
The regulation of calcium (Ca 2þ ) reabsorption in the kidney is crucial for the maintenance of Ca 2þ balance [1, 2 ] . It is generally known that only 1-3% of Ca 2þ that is filtered by the kidney is excreted. The majority of Ca 2þ reabsorption occurs passively along the proximal tubule (PT) and the thick ascending limb of Henle's loop (TAL). Fine tuning of Ca 2þ reabsorption takes place along the distal convoluted tubule (DCT) and the connecting tubule (CNT), where the remaining 15% of filtered Ca 2þ is transcellularly reabsorbed [2 ,3] (Fig. 1a) . This latter process can be divided into three discrete steps. The first step requires Ca 2þ influx across the apical membrane. Hoenderop et al. [4] identified the transient receptor protein-vanilloid TRPV5 as the responsible protein in this process. The second step is the facilitated diffusion of Ca 2þ through the cytosol. Here, calbindin-D 28k binds intracellular Ca 2þ transported via TRPV5 and shuttles it through the cytosol towards the basolateral membrane where Ca 2þ is extruded via the Na þ /Ca 2þ exchanger NCX1 and the Ca 2þ -ATPase PMCA1b, the final step in this process.
TRPV5
TRPV5 belongs to the transient receptor protein (TRP) super family, representing channels with a wide range of functions. Its diversity is reflected in tissue distribution, ion permeability, modes of activation and involvement in biological processes [5, 6 ]. Although all TRP channels mediate the influx of cations, TRPV5 has a strong preference for Ca 2þ [10] [11] [12] . Posttranscriptionally, TRPV5 activity is modulated by other proteins, most likely by affecting its protein conformation or by interfering with the intracellular trafficking of TRPV5 [13] [14] [15] [16] .
Recently, two new findings were presented that greatly enhance our knowledge about proximal [17 ] and distal [18 ] Ca 2þ reabsorption and the role of TRPV5 herein. In this review, both milestones are discussed in detail.
Thiazide-induced hypocalciuria due to increased passive Ca 2R reabsorption
Thiazide is a well known diuretic frequently used to treat arterial hypertension [19, 20] . The development of hypocalciuria, as one of its side-effects, is used to its advantage in the treatment of idiopathic hypercalciuria [21] . The responsible molecular mechanism remains to be conclusively identified, however. It has been known for a long time that the point of action of thiazides is located in DCTs, where Na þ reabsorption is inhibited by blockage of the apical Na þ -Cl À transporter, known as NCC [22] . This results in renal Na þ and water wasting, but is often also associated with hypomagnesemia and hypocalciuria [19, 20] . Linkage analysis for Gitelman's . NCC blockage by hydrochlorothiazide leads to reduced Na þ reabsorption in DCT. This will induce extracellular volume (ECV) contraction due to renal salt and water loss [47] . To accommodate this, ECV contraction will result in a compensatory increase in renal proximal Na þ reabsorption, thereby enhancing the electrochemical gradient ultimately leading to increased passive paracellular Ca 2þ reabsorption. Klotho exerts its effect by (partial) hydrolysis of the N-glycosylated TRPV5 channel, thereby stabilizing it in the apical plasma membrane. This will enable prolonged transcellular Ca 2þ transport across the epithelium.
syndrome resulted in the identification of NCC in humans [23] [24] [25] . The patients presented with hypomagnesemia and hypocalciuria, in addition to hypokalemia and metabolic alkalosis [26] . Schultheis et al. [27] created an NCC-knockout (NCC À/À ) mouse exhibiting identical phenotypes as described for Gitelman's syndrome and chronic thiazide treatment, supporting the central role of NCC in Na þ reabsorption in DCT.
The question remained of what the origin was of the hypocalciuria. Two options have been proposed [28, 29] : increased passive proximal Ca 2þ reabsorption due to extracellular volume (ECV) contraction [30] or increased active Ca 2þ reabsorption in DCT possibly due to hyperpolarization of the apical membrane [31] .
First models of thiazide action
The effect of thiazide on Ca 2þ reabsorption was observed by Lamberg and Kuhlback [32] in 1959 and Seitz and Jaworski [33] shortly thereafter. Around the same time, it was shown that chlorothiazide treatment results in ECV contraction, as measured by an increase in hematocrit [34] , although this effect was temporal. Micropuncture studies in rats initially pointed towards a prominent role for DCTs in the change in Na þ /Ca 2þ reabsorption ratio after acute thiazide treatment. Edwards et al. [35] showed that chlorothiazide treatment in dogs results in reduced glomerular filtration rate (GFR), increased Na þ excretion, and a decreased fractional Ca 2þ excretion. Micropuncture data showed that neither Na þ nor Ca 2þ reabsorption is affected in PTs, and distally only Na þ reabsorption was decreased. Costanzo and Weiner [36] concluded that volume depletion is not a necessary condition for the hypocalciuric response as injection of thiazide in the left renal artery of dogs only affected Ca 2þ clearance in the left kidney, while volume depletion would be expected to affect both kidneys. Subsequently, Costanzo and Windhager [37] performed micropuncture and microperfusion studies in rats to characterize thiazide-sensitive Ca 2þ transport. While Na þ load was increased in DCTs, Na þ reabsorption was reduced. Luminal Ca 2þ levels were also higher at the beginning of DCTs, suggesting a decreased Ca 2þ and Na þ absorption in PTs. The luminal Ca 2þ concentration in DCTs was significantly increased, supporting a role for this latter segment in thiazide-induced hypocalciuria.
Role of PTH
Brickman et al. [38] showed that patients with hypoparathyroidism do not develop hypocalciuria after thiazide treatment, in contrast to controls or hyperparathyroidic patients, suggesting an important role for PTH. Studies in thyro-parathyroidectomized dogs, however, showed that Ca 2þ excretion is decreased to a similar extent as control dogs after the acute application of chlorothiazide [36, 39] . In contrast, studies by Shimuzu et al. [40] showed that the addition of PTH is essential for acute thiazide-induced Ca 2þ transport in isolated rabbit CNTs . This effect could be inhibited by blocking the basolateral Na [42, 43] .
Thiazides and TRPV5
In 1999, TRPV5 was identified as the major epithelial Ca 2þ channel in DCTs and CNTs [4] . This discovery prompted the question of whether these channels constituted the missing link in thiazide-induced hypocalciuria. Nijenhuis et al. [29] showed that a chronic treatment of rats with a high dose of hydrochlorothiazide results in decreased mRNA levels of genes encoding for TRPV5, calbindin-D 28k , and NCX1. These results were at odds with a role for DCTs at the origin of thiazide-mediated hypocalciuria. Furthermore, chronic treatment of rats with hydrochlorothiazide induced ECV contraction and reduced urinary Ca 2þ excretion. Na þ repletion abolished ECV contraction and prevented the hypocalciuria. Lee et al. [44] studied the effects of acute and chronic treatment with lower doses of thiazide. Only acute treatment with low doses of chlorothiazide resulted in an upregulation of TRPV5 mRNA. Chronic chlorothiazide treatment caused volume depletion, which could be compensated by salt supplementation, confirming the data of Nijenhuis et al. [29] , but did not affect TRPV5 expression. The authors concluded that volume contraction after chronic thiazide treatment increases Ca 2þ reabsorption in the PTs.
A role for TRPV5 in thiazide-induced Ca 2þ reabsorption was challenged by Loffing et al. [45] . The authors showed that the thiazide-sensitive NCC is mainly located in DCT1, in contrast to TRPV5 which is present in DCT2 and CNTs [45] . In NCC À/À mice, DCT1 was virtually absent, while DCT2 was apparently intact and retained expression of TRPV5 and NCX1. Fractional delivery of Ca 2þ was decreased in PTs, but unaffected in DCTs. These data already suggest that TRPV5 -and DCT2 in general -play a marginal role, if any at all, in thiazide-induced hypocalciuria. The creation of a TRPV5-knockout (TRPV5 À/À ) mouse by Hoenderop et al. [46] could finally resolve the issue of the putative involvement of TRPV5. TRPV5 À/À mice are characterized by renal Ca 2þ wasting as a result of reduced Ca 2þ reabsorption in DCTs, accompanied by polyuria and reduced urinary pH [46] . Nijenhuis et al. [17 ] showed that chronic treatment with a relatively low dose of hydrochlorothiazide results in a strong reduction of urinary Ca 2þ excretion in both wild-type and TRPV5
À/À mice. Importantly, micropuncture data showed that Na þ , fluid, and Ca 2þ reabsorption in PTs is increased after hydrochlorothiazide treatment, while fractional Ca 2þ delivery in DCTs was reduced. Chronic low-dose treatment did not result in changes in mRNA and protein levels of TRPV5, calbindin-D 28k or NCX1, in contrast to high-dose hydrochlorothiazide treatment [29] , thereby confirming the data of Lee et al. [44] . The hematocrit was significantly increased in wild-type and TRPV5 À/À mice, indicative of volume depletion. This was associated with a decreased lithium clearance, an inverse measure for proximal tubular Na þ reabsorption and indirectly passive paracellular Ca 2þ transport. Also, protein levels of the proximal tubular Na þ /H þ exchanger NHE3 were significantly increased. Together, these data demonstrated that the passive paracellular Ca 2þ transport in PTs is enhanced after chronic thiazide treatment. In addition, a single dose of hydrochlorothiazide resulted in an acute temporary increase in Na þ excretion without affecting Ca 2þ . After this, however, hypocalciuria developed both in wild-type and in TRPV5 À/À mice, coinciding with a decrease in Na þ excretion.
In conclusion, recent data show that thiazide-induced Ca 2þ reabsorption occurs mainly in the proximal part of the nephron. Inhibition of Na þ reabsorption in DCTs will decrease ECV due to renal salt and water loss [47] . Consequently, ECV contraction results in a compensatory increase in renal proximal Na þ reabsorption, thereby enhancing the electrochemical driving force for paracellular Ca 2þ reabsorption (Fig. 1b) .
Klotho: a new player in Ca 2R reabsorption along distal convoluted tubules People have been striving for longevity for centuries. Nowadays, molecular biology can be applied to understand the molecular mechanism of aging. In 1997, Kuro-o et al. [48] discovered by random mutagenesis a mouse strain with a phenotype resembling premature aging in humans. These infertile mice developed arteriosclerosis, osteoporosis, skin changes, and ectopic calcification in several organs and died at an early age [48] . The allele associated with this phenotype carried a gene now called Klotho, named after the Greek goddess who spins the thread of life. Overexpression of Klotho in mice resulted in a significant extension of life span and a suppression of aging [49 ] . In humans, allelic variations are related to life expectancy and occult coronary artery disease [50,51 ,52] . The Klotho gene encodes a singlepass transmembrane protein with an N-terminal signal sequence, a putative extracellular domain with two internal repeats and a short intracellular domain on the carboxy terminus. The gene is mainly expressed in DCTs of the kidney, the choroid plexus in the brain [18 ,48] , and the parathyroid gland [53] . Klotho exhibits b-glucuronidase activity [54] and is activated by cleavage of the N-terminal extracellular tail. This part is then released into the urine, serum and cerebrospinal fluid [18 ,55] .
Klotho and Ca 2R homeostasis
Klotho-deficient mice (kl/kl) have slightly increased plasma levels of Ca 2þ [48] . This was associated with high levels of 1,25-(OH) 2 D 3 caused by increased expression of renal 1a-hydroxylase, the rate-limiting step in 1,25-(OH) 2 D 3 synthesis [56, 57] . Dietary suppression of 1,25-(OH) 2 D 3 levels normalized most of the kl/kl phenotype [58] . Conversely, Tsujikawa et al. [58] showed that administration of 1,25-(OH) 2 D 3 induces Klotho expression in the kidney. PTH levels were decreased and calcitonin levels were increased in adult kl/kl mice, correlating with the increased plasma Ca 2þ levels. These data suggested that this correction mechanism is not affected in kl/kl mice and that Klotho may act in a negative regulatory circuit of vitamin D.
One of the first signs that Klotho plays a role in Ca 2þ metabolism was the observation that kl/kl mice develop bone abnormalities, including osteoporosis [48] . Kl/kl mice had an $20% lower bone mineral density than control mice. This has been confirmed in humans, where some allelic variants are associated with osteoporosis and spondylosis [59, 60] . In kl/kl mice, both osteoblast and osteoclast differentiation were impaired [61, 62] . The decrease in bone formation exceeded that of bone resorption, however, resulting in a net bone loss [61] , the phenotype resembling that of humans suffering from senile osteoporosis. Osteoporosis in kl/kl mice was associated with abnormal elongation of the trabecular bones in the epiphyses of long bones. This is likely the result of the reduced bone resorption, in part due to a reduced number of osteoclasts [63] .
Recently, Chang et al. studied the relationship between TRPV5 and Klotho [18 ] . Microarray data revealed that Klotho expression is decreased in TRPV5 À/À mice. Coexpression of Klotho with TRPV5 in human embryonic kidney 293 (HEK293) cells, or application of purified Klotho to TRPV5-expressing HEK293 cells, significantly stimulated 45 Ca 2þ uptake in these cells. Cell surface biotinylation experiments revealed a significant increase in plasma membrane localization of TRPV5 whereas total expression was not affected after Klotho treatment. These effects could be mimicked by a purified b-glucuronidase indicating that the enzymatic activity of Klotho is responsible for the increased TRPV5 activity. Klotho had no effect on a nonglycosylated mutant of TRPV5 (N358Q), indicating that Klotho may work by affecting the extracellular glycosylation status of the channel, entrapping the channels in the plasma membrane, thereby increasing TRPV5-mediated Ca 2þ influx activity (Fig. 1b) .
During aging, Ca 2þ loss predominates Ca 2þ intake [64] . As Klotho deficiency is associated with a phenotype resembling aging, it may well be that impaired Klotho activity in the elderly is responsible for reduced Ca 2þ reabsorption via TRPV5. Future studies will have to further substantiate this notion. The discovery of the extracellular enzymatic effect of Klotho on TRPV5 activity has greatly enhanced our understanding of Klotho functioning and may prove to be the role model in unravelling the antiaging effect of this novel hormone with enzymatic activity.
Conclusion
New exciting developments in renal Ca 2þ reabsorption are presented in this review. Thiazides are known to affect the Ca 2þ balance inducing hypocalciuria, and have been suggested as exerting favorable long-term effects in counteracting osteoporosis. It took more than 40 years to unravel the mechanism responsible for thiazide-induced hypocalciuria, which could only be addressed conclusively after the creation of the TRPV5 À/À mouse. Regulation of TRPV5 can be considered as the fine-tuning step of renal Ca 2þ reabsorption. The finding that Klotho regulates TRPV5, and thereby total Ca 2þ reabsorption, is a major step forward in our understanding of the relationship between Ca 2þ reabsorption and aging.
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